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Phenotype
When we discuss variable penetrance or expressivity of
mutations, we often use a hand-waving argument that
genetic variation in a second gene could be influencing
penetrance of the disease mutation. With recent work by
Law et al., this hand waving can become finger pointing,
directed at a tandem repeat sequence that explains variable
expression of the alpha thalassemia/X-linked intellectual
disability (ATRX) syndrome phenotype. Even when two
individuals have the same ATRX mutation, there is vari-
ability in the phenotype of the resulting ATRX syndrome,
particularly in the severity of the alpha thalassemia
component of the phenotype. Whereas some individuals
with ATRX mutations have a microcytic anemia due to
the downregulation of alpha globin expression, others
have normal red cell indices. Law et al. tie these loose
ends together through a chromatin immunoprecipita-
tion-sequencing (ChIP-Seq) approach that indicates that
ATRX has an affinity for G-rich tandem repeats. Indeed,
ATRX seems to prefer to bind G-quadruplex structures, at
least in vitro. One of the binding sites is a VNTR that is
close to the alpha-like globin genes. As it turns out, varia-
tion in the length of this VNTR governs the variability in
alpha globin expression in individuals with ATRX muta-
tions. Cells from patients with the largest number of
repeats at this VNTR have the biggest reduction in expres-
sion of alpha globin and, at the extreme, can exhibit
monoallelic expression of the alpha globin gene.
Law et al. Cell 143, 367–378.
Accidents Do Happen; Quite Often, In Fact
It takes many, many genes to form a human brain and to
facilitate normal postnatal brain development. This leaves
many mutational targets that can lead these processes to
go awry, making genetic testing for intellectual disability
quite complicated. As our ability to detect genetic variation
has improved, so has our ability to explain the genetic
underpinnings of intellectual disability. The fact remains,
however, that intellectual disability comprises a very
heterogeneous group of disorders that can be the result
of mutations at many different positions in the genome,
leaving the underlying cause undiscovered in a significant
fraction of cases. Recent work suggests that exome
sequencing may help us find the needle-in-the-haystack
mutations in many of these previously unexplained cases.1Department of Human Genetics, Emory University School of Medicine, Atlan
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The AmericanVissers et al. sequenced the exomes from ten individuals
with sporadic, unexplained intellectual disability and their
parents. Sorting through the variation, they honed in on
changes that were predicted to be functional changes
within genes and were de novo in the affected children.
They found six different likely pathogenic mutations
in six different patients, each in a different gene. These
included two genes that were already known to cause
intellectual disability when mutated, providing proof of
principle for the analysis. Beyond finding a likely genetic
cause in a number of affected people, this work also
suggests that de novo point mutations could explain a
significant fraction of sporadic cases of intellectual
disability.
Vissers et al. Nature Genetics Advance Online Publication.
Published online November 14, 2010. 10.1038/ng.712.
WDR62 Proves Multitalented in Brain Development
To form a normal brain, neural precursors must first
undergo a set of symmetric cell divisions to produce a suffi-
cient number of neural progenitor cells. Next comes a series
of asymmetric cell divisions that give rise to cells that will
differentiate into neurons and migrate to the appropriate
location in the cortex. If too few of the symmetric cell
divisions occur, there aren’t enough neural progenitors,
and you get microcephaly. It was thought that defects in
other stages of this process would give rise to different mal-
formations of cortical development. Recent work described
in a series of recent papers has identified WDR62 as a
protein that links the different phases of development.
WDR62 is mutated in individuals with primary micro-
cephaly and in others with microcephaly and additional
cortical defects. As with other proteins implicated in
microcephaly, WDR62 is localized to mitotic spindles in
dividing neural precursors, but it moves into the nucleus
in young neurons and influences neuronal migration.
The precise mutation in WDR62 determines which func-
tion of the protein is affected. Missense mutations that
are found in individuals with primary microcephaly
prevent WDR62 from localizing to the spindle pole. On
the other hand, more severemutations affect both prolifer-
ation and neuronal migration and result in a more severe
phenotype.
Nicholas et al. Nature Genetics 42, 1010–1014; Wollnik.
Nature Genetics 42, 923–924; Yu et al. Nature Genetics 42,
1015–1020.ta, GA 30322, USA
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BPA Quells Double-Strand Break Repair
‘‘BPA Free!’’ read the stickers on water bottles near and far,
as a result of accumulating evidence that bisphenol-A
(BPA) could increase the risk of reproductive issues and
certain diseases, such as diabetes and heart disease.
Although some studies indicate that BPA has no significant
health impact, data in rodents suggest that it disrupts
meiosis, and at least one study found a correlation between
urinary BPA and risk of miscarriage in women. To nail
down the effects of BPA on meiosis, Allard and Colaiacovo
turn to a simpler model system: C. elegans. BPA exposure,
albeit at quite high levels, has drastic effects on fertility
and on the survival of C. elegans embryos. Through its
antiestrogenic activity, BPA decreases germline expression
of genes involved in double-strand break repair, impairing
this protective mechanism and leading to chromosome
abnormalities in oocytes of exposed worms. Although
the levels of BPA in these experiments were higher than
what we’d expect for a typical human exposure, this type
of study could tease apart the relevant pathways through
which BPA is acting and lead to further understanding of
its risks.
Allard and Colaiacovo. PNAS. Published online November 8,
2010. 10.1073/pnas.1010386107.
HLA Clamps Down on HIV
A small but significant fraction of the people infected with
HIV, dubbed controllers, are able to limit viral replication740 The American Journal of Human Genetics 87, 739–741, Decemband maintain high CD4þ T cell counts and low viral loads,
even in the absence of antiretroviral therapy. A recent
genome-wide association study (GWAS) compared the
genomes of a large number of these controllers against
those of people with advanced disease due to HIV and
hit a bulls-eye in the binding pocket of HLA-B. The only
significant associations from the GWAS were with SNPs
in the major histocompatibility complex (MHC) region
on chromosome 6. This region has been implicated in
HIV control previously but has been a headache in genetic
association studies in general because of high levels of
linkage disequilibrium. To sort through the data and find
the key variation associated with HIV control, the authors
imputed amino acid residues from genotype data and used
them in further association analysis. Five residues that line
the binding groove of HLA-B are major players in this
association, frequently differing between controllers and
those with advanced disease. This groove is the portion
of HLA-B to which viral epitopes are bound for presenta-
tion to CD8þ T cells, suggesting that activation of these
cytotoxic T cells is the key to viral control. Understanding
how these residues influence viral antigen presentation
could leave us better able to manipulate this process in
noncontrollers and potentially to design effective HIV
vaccines.
The International HIV Controllers Study. Science Express.
Published online November 4, 2010. 10.1126/science.
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The chromosome ends, or telomeres, gradually get shorter
as a person ages, because the DNA can’t be copied all the
way to the ends during replication. This normal telomere
shortening is believed to contribute to aging phenotypes.
However, some people start life with abnormally short
telomeres due to single-gene mutations. A recent review
by Savage and Bertuch provides a thorough overview of
these telomere biology disorders, including the genes
involved and the range of features associated with these
mutations. Although the classic, andmost severe, telomere
biology disorder is dyskeratosis congenital (DC), we now
recognize a range of phenotypes associated with telomere
shortening. A triad of features is used to recognize DC—
abnormal nail development, abnormal skin pigmentation,
and oral leukoplakia—but the phenotype in affected indi-
viduals can also include bone marrow failure, cancer, and
pulmonary fibrosis. The phenotype of a telomere biology
disorder can be more subtle; some people with apparently
isolated features, such as acquired aplastic anemia, idio-
pathic pulmonary fibrosis, or liver disease, have now
been found to have mutations that result in short telo-
meres. Even within a single family, there can be quitevaried expression of the same mutation, and genetic
anticipation can be observed.
Savage and Bertuch. Genetics in Medicine. Published online
October 15, 2010. 10.1097/GIM.0b013e3181f415b5.
Is There Really a Missing-Heritability Problem?
Although genome-wide association studies have been very
successful at identifying risk alleles for complex genetic
traits, many researchers have remarked on the problem
of missing heritability; in other words, the fact that the
identified risk alleles for a particular trait, together, don’t
fully explain the trait heritability. Various explanations
for this missing-heritability problem have been proposed,
but now Song et al. use modeling studies to support the
idea that perhaps this heritability isn’t missing at all, or at
least not completely. Typically, we combine risk informa-
tion from multiple alleles by using a multiplicative model,
which assumes that the individual loci behave indepen-
dently. Song et al. calculate recurrence risk to close relatives
under different models and find that the results often yield
higher estimated recurrence risk than is predicted under
a multiplicative model, particularly when the risk alleles
are rare. What this means is that gene-gene interactionser 10, 2010
could account for more heritability than is often assumed.
Although these results need to be confirmedwith empirical
data, they suggest thatwe don’t necessarily need to go look-
ing for more loci that contribute to complex genetic traits;
we just need to be able to more effectively model gene-The Americangene interactions by using the data we already have. This
is easier said than done, as the effect of each individual
interaction isn’t going to follow the same model.
Song et al. Genetics Advance Online Publication. Published
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